AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:GDPH3552SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AMAG Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

AMAG Pharmaceuticals Inc (AMAG) is a pharmaceutical company focused on the development and commercialization of specialty pharmaceutical products in therapeutic areas like maternal, women’s health, anemia management and hematology. Its products portfolio include Makena an auto-injector device, Feraheme for intravenous, Intrarosa for vaginal inserts and Vylees an auto-injector device. The company is developing two product pipelines; Ciraparantag is in Phase 2b trial of healthy volunteers and AMAG-423 is in phase 2b/3a trial. The company offers its products through a direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc Key Recent Developments

Oct 02,2020: Covis Group to acquire AMAG Pharmaceuticals for $647m
Aug 06,2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12,2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11,2020: AMAG Pharmaceuticals announces leadership changes
May 12,2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AMAG Pharmaceuticals Inc – Key Facts
AMAG Pharmaceuticals Inc – Key Employees
AMAG Pharmaceuticals Inc – Key Employee Biographies
AMAG Pharmaceuticals Inc – Major Products and Services
AMAG Pharmaceuticals Inc – History
AMAG Pharmaceuticals Inc – Company Statement
AMAG Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AMAG Pharmaceuticals Inc – Business Description
Product Category: Feraheme
Performance
Product Category: Intrarosa
Performance
Product Category: Makena
Performance
Product Category: Other
Performance
R&D Overview
AMAG Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
AMAG Pharmaceuticals Inc – Strengths
AMAG Pharmaceuticals Inc – Weaknesses
AMAG Pharmaceuticals Inc – Opportunities
AMAG Pharmaceuticals Inc – Threats
AMAG Pharmaceuticals Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Aug 06, 2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12, 2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11, 2020: AMAG Pharmaceuticals announces leadership changes
May 12, 2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site
May 11, 2020: AMAG Pharmaceuticals announces first quarter 2020 financial results and provides corporate update
Apr 28, 2020: AMAG Pharmaceuticals appoints Scott Myers as president and chief executive officer
Apr 16, 2020: AMAG Pharmaceuticals provides COVID-19 company update
Mar 04, 2020: AMAG Pharmaceuticals announces changes to medical development organization
Mar 04, 2020: AMAG Pharmaceuticals reports fourth quarter and full year 2019 financial results and provides corporate update
Jan 09, 2020: AMAG Pharmaceuticals announces leadership transition, results of strategic review to unlock shareholder value and financial update
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
AMAG Pharmaceuticals Inc, Key Facts
AMAG Pharmaceuticals Inc, Key Employees
AMAG Pharmaceuticals Inc, Key Employee Biographies
AMAG Pharmaceuticals Inc, Major Products and Services
AMAG Pharmaceuticals Inc, History
AMAG Pharmaceuticals Inc, Other Locations
AMAG Pharmaceuticals Inc, Subsidiaries
AMAG Pharmaceuticals Inc, Key Competitors
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary

★海外企業調査レポート[AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inpex Corp (1605):石油・ガス:M&Aディール及び事業提携情報
    Summary Inpex Corp (Inpex) is an integrated energy company. It explores for, develops and produces oil and natural gas from its assets in domestic and international regions. The company markets crude oil, condensate, natural gas, and LNG. Inpex has working interest in various upstream projects in Eu …
  • Corgenix Medical Corp-医療機器分野:企業M&A・提携分析
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • MISC Berhad:企業の戦略・SWOT・財務情報
    MISC Berhad - Strategy, SWOT and Corporate Finance Report Summary MISC Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Exxon Mobil Corporation:企業のM&A・事業提携・投資動向
    Exxon Mobil Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exxon Mobil Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Interfor Corp:企業の戦略・SWOT・財務情報
    Interfor Corp - Strategy, SWOT and Corporate Finance Report Summary Interfor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Baldwin & Lyons Inc:企業の戦略・SWOT・財務情報
    Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report Summary Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Proteostasis Therapeutics Inc (PTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteostasis Therapeutics Inc (Proteostasis) is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company’s portfolio spans drug candidates for cystic fibrosis, neurodegenerati …
  • Solid Biosciences Inc (SLDB):製薬・医療:M&Aディール及び事業提携情報
    Summary Solid Biosciences Inc (Solid Biosciences) is a life science company focused on developing therapies for duchenne muscular dystrophy (DMD). Its pipeline product candidates include SGT-001, a microdystrophin gene therapy administered through adeno-associated virus (AAV) stabilizes dystrophin g …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Marinus Pharmaceuticals Inc (MRNS):製薬・医療:M&Aディール及び事業提携情報
    Summary Marinus Pharmaceuticals Inc (Marinus) is a clinical stage biopharmaceutical company that manufactures and commercializes therapeutics for the treatment of epilepsy, neuropsychiatric disorders and others diseases. The company’s pipeline product comprise ganaxolone is a CNS-selective GABAA mod …
  • OncoSil Medical Ltd (OSL):企業の財務・戦略的SWOT分析
    Summary OncoSil Medical Ltd (OncoSil), is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous …
  • UCB Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, meta …
  • Pharmadax Inc (4191):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmadax Inc (Pharmadax) is a drug development and generic specialty pharmaceutical company. The company develops modified release generics in various therapeutic segments. It offers products such as glyburide, quetiapine fumarate ER and metoprolol succinate ER. Pharmadax provides in the pr …
  • Grupo Farma:企業の戦略的SWOT分析
    Grupo Farma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Industrial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • TOA Corporation:企業の戦略・SWOT・財務分析
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ICA Gruppen AB:企業のM&A・事業提携・投資動向
    ICA Gruppen AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICA Gruppen AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆